Manfred W. Schmolz

Myriad RBM, Inc. provides protein biomarker products and services. Its biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. The company was founded in 1998 and is headquartered in Salt Lake City, UT.

Part of Q2 Solutions, Experimentelle & Diagnostische Immunologie GmbH is a German company that provides individual services and customized test systems for drug development. The company is based in Reutlingen, Germany. The company's innovative organotypic test systems focus on the complexity of the human immune system, and their hot screen culture systems help to reduce attrition rates in later clinical phases. The company offers whole blood cultures for activity profiling of drugs and materials acting on cells of the human immune system. The company was founded by Manfred W. Schmolz. Experimentelle & Diagnostische Immunologie was acquired by Myriad RBM, Inc., part of Q2 Solutions from July 01, 2021 on October 09, 2007.

Vitro Biopharma, Inc. develops and commercializes adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. Its products include cell culture media, cell lines, and nutravivo-dietary-supplements. The company was founded by James R. Musick on March 31, 1986 and is headquartered in Denver, CO.